HEALTH● LOWSep 15 · Sep 15, 2026, 5:50 PM
Psychedelic Drug Wins Third Phase 3 Anxiety Trial
Human Progress · global
“Definium Therapeutics has scored a third straight phase 3 win for its LSD formula, with the psychedelic significantly alleviating anxiety symptoms and setting up an FDA filing next year. While the Panorama trial did compare Definium’s DT120 ODT to placebo, the study also pitted the 100 μg dose against a 50 μg dose, which is […] The post Psychedelic Drug Wins Third Phase 3 Anxiety Trial appeared first on Human Progress.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH28m agoHealth Minister rules out withdrawal of hospital billing transparency orderThe HinduHEALTH41m agoEli Lilly's Omvoh boosted by new ulcerative colitis, Crohn's dataSeeking Alpha TechHEALTH48m agoCanadians Overwhelmingly Support a Smoke - Free Generation Law , a New Poll Commissioned by National Lung Health Alliance Findssimcoereformer.ca · CanadaHEALTH1h agoToluwanisings was rushed to 8 hospitals before death – PAVanguard Nigeria